Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Epistasis Analysis01:09

Epistasis Analysis

Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of the CP-violating phase ϕs in Bs(0)→Ds(+)Ds(-) decays.

Physical review letters·2014
Same author

Depressive symptoms and adverse outcomes from hospitalization in older adults: secondary outcomes of a trial of falls prevention education.

Archives of gerontology and geriatrics·2014
Same author

Measurement of the B¯s⁰ meson lifetime in Ds⁺π⁻ decays.

Physical review letters·2014
Same author

Test of lepton universality using b+ → K+ℓ+ℓ- decays.

Physical review letters·2014
Same author

First observation of a baryonic Bc+ decay.

Physical review letters·2014
Same author

Observation of overlapping spin-1 and spin-3 D0K- resonances at mass 2.86 GeV/c2.

Physical review letters·2014

Related Experiment Video

Updated: Jul 8, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Identifying genes predisposing to atopic eczema.

S Forrest1, K Dunn, K Elliott

  • 1Murdoch Institute for Research into Birth Defects, Parkville, Victoria, Australia.

The Journal of Allergy and Clinical Immunology
|November 7, 1999
PubMed
Summary
This summary is machine-generated.

Researchers identified a gene predisposing to atopic eczema on chromosome 5q31. This finding helps define genetic factors for atopic diseases, distinguishing general predisposition loci from those determining specific phenotypes.

More Related Videos

Identification of the Genes Involved in Stomatal Development via Epidermal Phenotype Scoring
05:22

Identification of the Genes Involved in Stomatal Development via Epidermal Phenotype Scoring

Published on: January 20, 2023

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology
12:34

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology

Published on: January 12, 2024

Related Experiment Videos

Last Updated: Jul 8, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Identification of the Genes Involved in Stomatal Development via Epidermal Phenotype Scoring
05:22

Identification of the Genes Involved in Stomatal Development via Epidermal Phenotype Scoring

Published on: January 20, 2023

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology
12:34

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology

Published on: January 12, 2024

Area of Science:

  • Genetics and immunology
  • Dermatology
  • Allergy research

Background:

  • Atopic diseases like asthma and eczema result from genetic and environmental factors.
  • The specific gene(s) responsible for atopy remain undefined.
  • Identifying genetic predispositions is challenging due to heterogeneity and bias.

Purpose of the Study:

  • To identify specific genes predisposing to atopic eczema.
  • To investigate candidate regions on chromosomes 5q31, 11q13, 14q11.2, and 16p12.

Main Methods:

  • Studied nuclear families with early-onset atopic eczema.
  • Analyzed linkage for candidate regions including the IL gene cluster (5q31) and IL-4 receptor alpha-chain (IL4RA).
  • Employed recessive genetic models and transmission disequilibrium tests.

Main Results:

  • Found significant linkage (LOD score 2.25, nonparametric score 2.54) to a region on chromosome 5q31.
  • Postulated the presence of an atopic eczema predisposing gene in this 5q31 region.
  • Did not find linkage to 11q13 or association with candidate polymorphisms in mast cell chymase and IL4RA genes.

Conclusions:

  • Identified a clinically homogeneous cohort for genetic factor discovery.
  • Postulate distinct loci for general atopy predisposition and specific phenotype determination.
  • The 5q31 region is a key area for further investigation into atopic eczema genetics.